MeiraGTx Holdings Management
Management criteria checks 2/4
MeiraGTx Holdings' CEO is Alexandria Forbes, appointed in Mar 2015, has a tenure of 10.58 years. total yearly compensation is $6.88M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 1.69% of the company’s shares, worth $11.44M. The average tenure of the management team and the board of directors is 6.3 years and 10.3 years respectively.
Key information
Alexandria Forbes
Chief executive officer
US$6.9m
Total compensation
| CEO salary percentage | 12.22% |
| CEO tenure | 10.6yrs |
| CEO ownership | 1.7% |
| Management average tenure | 6.3yrs |
| Board average tenure | 10.3yrs |
Recent management updates
Recent updates
MeiraGTx: Hologen Partnership Makes Parkinson's Gene Therapy Vital
Sep 25There's Reason For Concern Over MeiraGTx Holdings plc's (NASDAQ:MGTX) Price
Sep 23
News Flash: Analysts Just Made A Captivating Upgrade To Their MeiraGTx Holdings plc (NASDAQ:MGTX) Forecasts
Aug 20Would MeiraGTx Holdings (NASDAQ:MGTX) Be Better Off With Less Debt?
Jul 04Some Confidence Is Lacking In MeiraGTx Holdings plc (NASDAQ:MGTX) As Shares Slide 25%
May 29Is MeiraGTx Holdings (NASDAQ:MGTX) Using Debt Sensibly?
Apr 04MeiraGTx Holdings: Gaining Regulatory Focus
Mar 25MeiraGTx Holdings plc's (NASDAQ:MGTX) 29% Price Boost Is Out Of Tune With Revenues
Mar 14MeiraGTx: 2 Possible Near-Term BLA Filings Could Ignite Shareholder Value
Jan 22Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results
Nov 15MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings
Oct 15MeiraGTx: A Very Attractive Longer-Term Play, With Potential Near-Term Catalysts
Jul 15MeiraGTx Holdings (NASDAQ:MGTX) Has Debt But No Earnings; Should You Worry?
Jun 19MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met
Feb 15Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?
Sep 08Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)
Apr 11MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year
Mar 16MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be
Nov 16MeiraGTx GAAP EPS of -$0.76, revenue of $10.76M
Aug 11MeiraGTx inks $100M debt agreement backed by manufacturing facilities
Aug 03CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | -US$158m |
| Mar 31 2025 | n/a | n/a | -US$167m |
| Dec 31 2024 | US$7m | US$840k | -US$148m |
| Sep 30 2024 | n/a | n/a | -US$88m |
| Jun 30 2024 | n/a | n/a | -US$93m |
| Mar 31 2024 | n/a | n/a | -US$74m |
| Dec 31 2023 | US$6m | US$648k | -US$84m |
| Sep 30 2023 | n/a | n/a | -US$132m |
| Jun 30 2023 | n/a | n/a | -US$125m |
| Mar 31 2023 | n/a | n/a | -US$129m |
| Dec 31 2022 | US$8m | US$580k | -US$130m |
| Sep 30 2022 | n/a | n/a | -US$112m |
| Jun 30 2022 | n/a | n/a | -US$101m |
| Mar 31 2022 | n/a | n/a | -US$87m |
| Dec 31 2021 | US$6m | US$580k | -US$80m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$61m |
| Mar 31 2021 | n/a | n/a | -US$66m |
| Dec 31 2020 | US$8m | US$602k | -US$58m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$52m |
| Dec 31 2019 | US$8m | US$580k | -US$55m |
| Sep 30 2019 | n/a | n/a | -US$70m |
| Jun 30 2019 | n/a | n/a | -US$75m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$23m | US$555k | -US$85m |
Compensation vs Market: Alexandria's total compensation ($USD6.88M) is above average for companies of similar size in the US market ($USD3.56M).
Compensation vs Earnings: Alexandria's compensation has increased whilst the company is unprofitable.
CEO
Alexandria Forbes (60 yo)
Dr. Alexandria Forbes, Ph.D. serves as the Chief Executive Officer, Director and President at MeiraGTx Holdings plc (formerly known as MeiraGTx Limited) since March 2015. Prior to joining MeiraGTx, Dr. For...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 10.6yrs | US$6.88m | 1.69% $ 11.4m | |
| COO & CFO | 10.6yrs | US$6.69m | 1.17% $ 7.9m | |
| Chief Development Officer | 10.5yrs | US$2.03m | 0.77% $ 5.2m | |
| General Counsel & Secretary | 6.2yrs | no data | 0.039% $ 261.7k | |
| Head of Clinical Ophthalmology | 4.8yrs | no data | no data | |
| Senior Vice President of Global Integration | no data | no data | no data | |
| Senior Vice President of Risk & Internal Controls | 6.5yrs | no data | no data | |
| Chief Medical Officer | 5.2yrs | US$4.05m | 0.17% $ 1.1m | |
| Senior Vice President of Business Development | 4.8yrs | no data | no data |
Experienced Management: MGTX's management team is seasoned and experienced (6.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 10.6yrs | US$6.88m | 1.69% $ 11.4m | |
| Member of Scientific Advisory Board | no data | US$149.82k | no data | |
| Independent Director & Member of Scientific Advisory Board | 10.3yrs | US$313.90k | 0% $ 0 | |
| Independent Chairman of the Board | 10.3yrs | US$529.12k | 0.16% $ 1.0m | |
| Independent Director | 6.4yrs | US$323.92k | 0.0062% $ 42.0k | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 10.3yrs | US$314.20k | 0.016% $ 108.2k | |
| Director | 8yrs | US$219.15k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
Experienced Board: MGTX's board of directors are seasoned and experienced ( 10.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 05:32 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MeiraGTx Holdings plc is covered by 15 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Huidong Wang | Barclays |
| Alec Stranahan | BofA Global Research |
| Gbolahan Amusa Benz | Chardan Capital Markets, LLC |